Volume 99, Issue 1, Pages e3 (July 2018)

Slides:



Advertisements
Similar presentations
Volume 42, Issue 1, Pages (January 2015)
Advertisements

Volume 6, Issue 5, Pages (November 2009)
Volume 36, Issue 6, Pages (June 2012)
Volume 41, Issue 4, Pages (October 2014)
Volume 47, Issue 1, Pages e10 (July 2017)
Volume 45, Issue 1, Pages (July 2016)
Volume 13, Issue 6, Pages (November 2015)
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Volume 18, Issue 5, Pages (May 2010)
Volume 8, Issue 1, Pages (January 2017)
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 5, Issue 1, Pages (January 2009)
Volume 146, Issue 6, Pages (September 2011)
Volume 6, Issue 4, Pages (October 2009)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 36, Issue 3, Pages (March 2012)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Volume 31, Issue 1, Pages (July 2009)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Volume 46, Issue 4, Pages (April 2017)
Volume 20, Issue 1, Pages (July 2016)
Volume 42, Issue 4, Pages (April 2015)
Volume 7, Issue 2, Pages (February 2010)
Volume 37, Issue 1, Pages (July 2012)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 78, Issue 4, Pages (May 2013)
Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6 Production  Rui Aoki, Tatsuyoshi Kawamura, Fumi.
Volume 24, Issue 5, Pages (May 2016)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 44, Issue 3, Pages (March 2016)
Volume 19, Issue 2, Pages (February 2016)
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Volume 22, Issue 1, Pages e7 (July 2017)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 23, Issue 2, Pages e7 (February 2018)
Volume 20, Issue 2, Pages (February 2013)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Rita U. Lukacs, Sanaz Memarzadeh, Hong Wu, Owen N. Witte 
Volume 23, Issue 2, Pages e7 (February 2018)
Volume 33, Issue 4, Pages (October 2010)
Volume 13, Issue 6, Pages (November 2015)
Volume 100, Issue 6, Pages (December 2018)
Volume 30, Issue 2, Pages (February 2009)
Volume 22, Issue 5, Pages e5 (November 2017)
Volume 17, Issue 5, Pages (May 2009)
Volume 166, Issue 5, Pages e4 (August 2016)
Volume 10, Issue 1, Pages (July 2011)
Volume 20, Issue 4, Pages (October 2016)
Volume 25, Issue 1, Pages (January 2017)
Volume 41, Issue 1, Pages (July 2014)
Volume 22, Issue 5, Pages e5 (November 2017)
Lukxmi Balathasan, Vera A
Volume 6, Issue 1, Pages (July 2009)
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Karen Laky, Sharron Evans, Ainhoa Perez-Diez, B.J. Fowlkes  Immunity 
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 29, Issue 3, Pages (March 2016)
Alphaherpesvirus Infection Disrupts Mitochondrial Transport in Neurons
Volume 46, Issue 4, Pages (April 2017)
Volume 90, Issue 3, Pages (May 2016)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Volume 71, Issue 5, Pages (September 2011)
Volume 13, Issue 6, Pages (November 2015)
Molecular Therapy - Oncolytics
Volume 49, Issue 4, Pages (February 2006)
Volume 25, Issue 4, Pages (April 2017)
Volume 166, Issue 5, Pages e4 (August 2016)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 99, Issue 1, Pages 56-63.e3 (July 2018) Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection  William A. Eimer, Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Alex S. Rodriguez, Teryn Mitchell, Kevin J. Washicosky, Bence György, Xandra O. Breakefield, Rudolph E. Tanzi, Robert D. Moir  Neuron  Volume 99, Issue 1, Pages 56-63.e3 (July 2018) DOI: 10.1016/j.neuron.2018.06.030 Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 Aβ42 Expression Increases Host Survival in an HSV1 Encephalitis 5XFAD Mouse Model Female transgenic mice (5XFAD), 5–6 weeks old, expressing human Aβ were compared against wild-type (WT) littermates for survival following bilateral intracranial injections of HSV1. Following injection of viable HSV1, WT and 5XFAD mice were followed for (A) survival and (B) weight loss. No mortality was observed among sham-infected control. Statistical significance was calculated by log-rank (Mantel-Cox) test for survival and statistical means compared by t test for weight loss. Survival analysis data were pooled from five independent experiments. Neuron 2018 99, 56-63.e3DOI: (10.1016/j.neuron.2018.06.030) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 2 Cell-Derived Aβ42 Oligomers Mediate HSV1 Resistance in Cell Culture Monolayer Infection Models Confluent human H4-N cell monolayers were co-incubated (2 hr) with HSV1-RFP fusion virus and conditioned media from transformed H4-Aβ42 (H4-Aβ42) or CHO-Aβ (CHO-Aβ) cells, anti-Aβ immunodepleted (ID) H4-Aβ42 (ID H4-Aβ42) and CHO-Aβ (ID CHO-Aβ) media, and synthetic (Aβ42) or scrambled (scAβ42) peptides treated to disrupt soluble oligomeric species. Host cell HSV1-RDP infection was assayed by flow cytometry. Signal shown as percentage of naive H4-N, CHO-N, or unconditioned media for H4-Aβ42, CHO-Aβ, and Aβ peptides, respectively. Bars are mean signal of replicates (n = 6) ±SEM. Statistical mean comparisons of naive and transformed signal were by t test. Data are representative of at least six independent experiments for each condition. Neuron 2018 99, 56-63.e3DOI: (10.1016/j.neuron.2018.06.030) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 3 Aβ Heparin-Binding Activity Mediates Binding of Herpesviridae Glycoproteins Aβ binding to heat-immobilized intact whole HSV1 particles was characterized in an Aβ-binding ELISA. (A) Wells containing immobilized HSV1 were incubated with transformed cell conditioned media (CHO-CAB) or synthetic Aβ42 (12.5 μg/mL) peptide (Syn Aβ42) alone or with mannan (+Mannan), or negative control anti-Aβ immunodepleted media (CHO-CAB ID), and probed for anti-Aβ signal. (B) HSV1 wells were pre-incubated with antibodies against HSV1 surface glycoproteins B (α-gB), C (α-gC), D (α-gD), E (α-gE), G (α-gG), and H (α-gH), and then incubated with H4-Aβ42 conditioned media. Signal shown as percentage of naive CHO-N or unconditioned media for CHO-CAB and Aβ peptides, respectively. Bars are mean signal of replicates (n = 6) ±SEM. Statistical mean comparisons were done by t test. Panels show data representative of finding from at least eight independent experiments. Neuron 2018 99, 56-63.e3DOI: (10.1016/j.neuron.2018.06.030) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 4 Aβ Fibrilization Mediates Viral Entrapment in 3D Human Stem Cell-Derived Neural Cell Culture and 5XFAD Mouse Infection Models Aβ fibrilization with HSV1 (HSV1), HHV6A (HHV6A), or HHV6B (HHV6B) infection was characterized in 3D cultures of GFP-expressing human neurons (host cells) and AD mouse models. Cell cultures and mouse brain sections were immunoprobed with anti-HSV1 (α-HSV1), anti-gB (α-gB), or anti-Aβ (α-Aβ) fluorophore-labeled antibodies and analyzed for green (GFP), red (RFP), and blue (405) fluorescence by confocal microscopy. (A) Virus preparations were incubated for 15, 30, or 120 min in H4-Aβ42 conditioned media and analyzed by TEM. (B and C) Three-week-old 3D cell cultures were left untreated (Uninfected) or incubated (48 hr) with virus and fluorescence signals captured under (B) low or (C) high magnification. (D and E) Wild-type (WT) and transgenic AD (5XFAD) female mice, 5–6 weeks old, were injected with HSV1 (+HSV1) or sterile vehicle (Uninfected) and brain sections immunoprobed for HSV1 and Aβ and stained for β-amyloid (β-amyloid) with Thioflavin S (ThS). Panels show (D) wide-field signal from brain 72 hr following injection with high (lethal) HSV1 titer and (E) high-magnification image of Aβ deposits in 5XFAD brain 21 days post-administration of non-lethal viral dose. Panels are representative of multiple image fields (>20) captured for each experimental condition. Neuron 2018 99, 56-63.e3DOI: (10.1016/j.neuron.2018.06.030) Copyright © 2018 Elsevier Inc. Terms and Conditions